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Abstract 
 The focus of this thesis is to understand the purpose of cognitive assessment exams while 
providing a detailed analysis and critique. This to understand their provided benefits and 
limitations in order to stimulate better clinical practice through implementation of these exams. 
This thesis first briefly details the history of humankind’s understanding of cognitive impairment 
and dementia. Then, the six major areas of cognition tested by most major cognitive exams are 
introduced and defined, including visual spatial, executive functions, verbal fluency, memory, 
attention, and orientation. The dysfunction in specific brain regions that lead to cognitive 
impairment is discussed, as well as how these brain regions regulate both general behavior and 
performance on different cognitive assessments. Next, six commonly used cognitive assessment 
exams are introduced including the Clock Draw Test (CDT), Trail Making Test (TMT), Verbal 
Fluency Exams, COGselftest (CST), Mini-Mental State Exam (MMSE), and the Montreal 
Cognitive Assessment (MOCA). This section provides background information on each exam, 
steps for how exams are administered, and also an analysis of the utility for each exam. 
Cognitive assessment exams are some of the most important tools utilized by healthcare 
providers to aid in the treatment of those with cognitive impairment and dementia. This paper 
aims to further detail their importance and provide insight into potential improvements including 
how to most effectively assess cognitive impairment and shaping these exams to distinguish 
types of dementias. 
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Introduction 
 The idea of dementia as a concept has been around for thousands of years. One of the 
earliest writings of dementia came from an ancient Greek philosopher known as Pythagoras. 
Pythagoras split the human lifecycle into five separate stages. The last two of which were 
attributed the title “senium” which indicated old age (Berchtold and Cotman, 1998). These two 
stages were described as the period in which both the human body and cognitive ability declined 
and decayed. The final stage was further described as one in which very few people were 
unfortunate enough to reach where the mind and body revert back to the stage of infancy 
(Berchtold and Cotman, 1998). Once just thought of as a natural process of aging, mild cognitive 
impairment (MCI) and dementia have plagued humanity for millennia. As average human 
lifespan increased however, this ailment became evermore present in society. As the number of 
individuals who were suffering from this mental state grew, so too did human’s curiosity in 
understanding it. It wasn’t until the late 1800’s when medicine and technology had developed 
enough to truly begin to understand the disease we now know as dementia. For the first time, 
humanity started to understand that there was a difference between normal age related cognitive 
decline and mild cognitive impairment and dementia. It wasn’t understood that MCI and 
dementia were due to disease, and not just an accepted part of aging, until the early 20th century.  
The first named, and most common, dementia was found in 1910 by a man named Alois 
Alzheimer (History of dementia research, 2017). Dr. Alzheimer began his research into dementia 
in 1906 studying the brains of individuals during post-mortem autopsies. In examining one 
patient who was in her 50’s and had presented with dementia-like symptoms through her later 
life, Alzheimer observed the beta-amyloid plaque and tau tangles we now attribute to dementia 
located in the brain tissue. Because of these initial findings, plaques and filaments are central 
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features of the disease known as Alzheimer’s Dementia. These early findings lead to a shift from 
accepting mild cognitive impairment and dementia as natural processes of ageing to the idea that 
they are products of a disease, one in which there may be a cure. 
Although the disease had been identified, medical advancements were stunned by the 
inability to study the brain of living subjects. It wasn’t until 1927 when a neurologist named 
António Egas Moniz performed the first cerebral arteriogram (Bakshi, 1997). The procedure is 
responsible for observing cerebral blood vessels to determine if there is a blockage. With this 
accomplishment came new opportunity. Being able to observe a living brain opened up a new 
door in treating people suffering from neurological diseases like dementia. Even though this new 
technology was unprecedented in its ability, the medium had to be refined before it could be 
truly effective. The discovery of the cerebral arteriogram led to the development of the 
computerized tomography (CT) scan in 1973 by an electrical engineer named Godfrey 
Hounsfield  based on the ideas of a neurologist named William Oldendorf (Bakshi, 1997). 
Finally, the physiological signs of dementia could be analyzed and studied in living patients. 
This, however, was not the end of the road. Neuroimaging could only show the physical state of 
the brain but didn’t give much insight into how that translated into behavior and specific 
cognitive function. This new technology had to be used in tandem with cognitive assessment 
exams in order to truly understand the malformations to behavior and cognitive ability dementia 
caused.  
Cognitive assessment exams are used to test certain aspects of cognitive ability in 
patients suspected of having MCI or some form of dementia. Areas of cognition these exams 
measure include memory, language, and executive function to name a few. In patients 
experiencing severe cognitive impairment, cognitive exams can be used to determine the 
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individual’s ability to perform regular tasks. For example, a patient’s ability to continue driving 
is typically assessed in a clinical setting using a trail making test (TMT). Trail making tests 
assess areas of cognition that are pertinent to driving such as speed and fluid intelligence 
(Salthouse, 2011). As such, clinicians can use the results of this exam to determine and 
recommend whether the patient is fit to continue driving. As indicated in this example, cognitive 
exams have an important advantage over neuroimaging. A patient’s ability can be assessed 
directly with cognitive assessment exams whereas it can only be hypothesized when looking at 
neuroimaging. This is why cognitive assessment exams are crucial to use in tandem with 
neuroimaging. Neuroimaging can only show you the areas of the brain that are impacted. Even 
with modern, high-resolution, scanning tools such as PET scans, which can label beta-amyloid 
plaque and tau-proteins, cognitive assessment exams must still be used. They are the only tool 
able to determine how these effected brain regions actually impact the patient in terms of 
cognition and behavior. Common cognitive assessment exams used today in clinics include short 
online exams such as the COGselftest, longer formal verbal exams such as the MOCA and 
MMSE, verbal fluency exams testing phonetic and semantic fluency, and written exams such as 
the clock draw and trail making tests. The primary limitation to most, if not all, cognitive 
assessment exams however is that they struggle to distinguish the type of dementia patients are 
suffering from. Rather, their focus is on determining the extent to which certain areas of 
cognition are impacted. The results of these exams, along with other factors such as medical 
history, genetics, lifestyle choices, and neuroimaging can, as one cohesive unit, be used to 
specify the specific nature of a patient’s dementia. 
 
Six Major Aspects of Cognition Tested in Cognitive Assessments 
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Different cognitive exams may focus on specific areas of cognition, however, there are 
six main areas of cognition most exams assess. These cognitive domains are visual spatial, 
executive functions, verbal fluency, memory, attention, and orientation. The visual spatial 
domain can be tested via locating and detailing specific aspects of a clock. Visual spatial deficits 
typically mean that the patient has trouble localizing an object and details of it in two- and three-
dimensional space (COGselftest.com, 2020). Typically, patients with visual spatial deficits have 
trouble accurately placing numbers on a clock face and struggle to draw proper hands to indicate 
a specific time. 
Figure 1: Progressive deterioration of visual spatial ability through Alzheimer’s Disease (AD) in 
a single patient (Mattson, 2014) 
 
 
The clock draw test, as seen in figure 1, is replicated in different ways depending on the 
medium of the exam. For example, the COGselftest has patients point to the location on a clock 
that specific numbers should go. Similar results are found here dependent on the stage of 
cognitive impairment the patient is in. Generally speaking, this is another positive aspect of 
cognitive evaluation exams because the intensity of cognitive impairment can be measured and 
compared overtime. Another example of severe visual spatial impairment is to ask a patient to 
point to a doorknob. A patient with visual spatial deficits may blindly point at a wall if anything. 
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However, if you ask a patient to leave the room, they will walk right to the door, open it with the 
doorknob, and walk out without any issue. Visual spatial impairment can be caused by cortical 
damage or atrophy in the occipital lobe, or associated areas of the parietal and temporal lobes 
(Cogselftest.com, 2020).  
 Executive functions are the second type of cognition typically evaluated from cognitive 
exams. The executive system is the part of the brain that controls cognition involving goal-
oriented planning, flexible strategy generation, sustaining set maintenance, self-monitoring, and 
inhibition (Takeuchi et al, 2013). Generally, it is easier to understand that executive function is 
responsible for our ability to conduct abstract thinking. Executive function can be tested in a few 
different ways. One of the most common ways is to ask patients to describe the similarities 
between two objects. For example, being able to explain that bananas and apples are both fruit, 
or that cats and dogs are both types of domestic pets. The MOCA is an example of a cognitive 
assessment exam that uses this strategy to test executive function. Another common test used to 
measure executive function is the trail making test (TMT) (Salthouse, 2011). These tests measure 
executive function by having the patient maintain a goal of connecting dots in specific ways. By 
doing this, their ability to plan in a goal-oriented manner and generate a strategy in completing 
that goal are tested. 
Figure 2: Trail Making Test example for someone with executive function impairment. The 
patient would have been instructed to draw a line between number to letter in increasing order 
starting with 1 and ending with 13. (Identifying neurodegenerative disease, 2020) 
 
Meghreblian 
 
8 
 
 
As indicated through measuring brain matter volume in comparison to performance of 
cognitive testing, cognitive impairment regarding executive function typically arises from 
damage or atrophy to the orbitofrontal cortex in the frontal lobe, dorsolateral prefrontal cortex, 
and the anterior cingulate cortex (Takeuchi, et al 2013). Executive function impairments are 
typically combatted by setting a rigid schedule for the patient that they follow every single day. 
This alleviates some of the stress faced by patients with these impairments as it limits their need 
to plan their day. 
 Verbal fluency is another highly tested area in cognitive exams. Generally, verbal fluency 
in terms of cognitive ability relates to how well a patient can form and utilize language. Patients 
with issues regarding verbal fluency may struggle with recalling the names of objects. They may 
be able to describe the object perfectly but be unable to recall its name. For instance, an 
individual with verbal fluency issues may be able to describe a phone presented to them as being 
something with a screen that lights up, and that you keep it in your pocket. However, they will be 
unable to say that the object is, in fact, a phone. Specific aspects of verbal fluency that are 
typically tested are vocabulary size, recall speed of certain words, and inhibition ability (Shao et 
al, 2014). These skills are tested via semantic and phonetic exams in which patients must present 
as many words as possible within a minute that fit specific criteria. Verbal fluency deficits have 
Meghreblian 
 
9 
been shown to largely be caused by damage to the superior medial and left inferior frontal lobe 
(Robinson et al, 2012). This was determined by administering lesion analysis among healthy 
patients and those with frontal lobe lesions and observing the performance of these groups on 
verbal fluency exams. Those with lesions in the superior medial and left inferior frontal lobe 
generally performed worse on verbal fluency assessment than did healthy patients. As seen in 
figure 3, patients suffering from Alzheimer’s Disease show especially severe verbal fluency 
deficits even when compared to those suffering from other cognitive impairments such as 
Amnestic (AMN) MCI. After subjecting these groups to an FAS verbal fluency test, it was 
apparent that those suffering from AMN MCI and Alzheimer’s Disease performed significantly 
worse than did those with non-AMN MCI and healthy controls. 
Figure 3: Average scores on FAS verbal fluency test between patients with Alzheimer’s, AMN 
MCI, non AMN MCI, and a normal comparison (NC) (Teng et al, 2013) 
 
 
 
However, even with this noted difference in performance, it has been found that verbal 
fluency exams, such as FAS phonetic exams, do not provide a large enough distinction between 
MCI and Alzheimer’s Disease (Teng et al, 2013). As such, verbal fluency exams are not precise 
enough to be solely used to differentiate between these two types of cognitive impairments. 
 The fourth major area of cognition typically tested by cognitive exams is memory. 
Specifically, the working memory aspects associated with short term memory is the focus of 
many neurocognitive assessments. The most common way to test short term memory on 
neurocognitive assessments is to assign the patient a recall task. A patient is usually presented 
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with 3 words then is given distraction tasks for 2-5 minutes before being asked to recall the 
presented words. This tests the patient’s ability to free recall, which is considered the aspect of 
cognition most sensitive to early diagnosis of dementia (Ivanoiu et al, 2005). As such, recall 
exams are extremely common throughout cognitive evaluation exams. They are present in online 
cognitive self-exams like the COGselftest, in the MMSE, and in the MOCA. A primary concern 
presented with these types of memory tests is their ability to recognize the problem the patient is 
facing. These tests can only show that the patient is having memory problems, but, memory 
problems don’t necessarily equate to MCI or dementia. After all, age-related memory loss is a 
natural, accepted part of aging and is distinct from both MCI and dementia.  
Upwards of 40 percent of adults over the age of 65 can experience age related memory 
deficits without having any neurophysiologic abnormalities (Alzheimer’s Society of Canada, 
2018). In addition, estimates reach up to 19 percent for adults over the age of 65 suffering from 
mild cognitive impairment that can limit memory (Gautheir et al, 2006). Whereas those suffering 
from MCI have decreased cognitive ability compared to others of the same age, it is still not as 
severe as other dementias such as Alzheimer’s Disease. In theory then, you can have a patient 
with age related memory deficit, a patient with MCI, and a patient with Alzheimer’s all perform 
the exact same on any given memory assessment. As such, many memory assessment 
evaluations cannot be used to distinguish cause of cognitive impairment, nor can they reliably be 
used to measure the potential decline of a patient slipping from healthy cognitive function to 
MCI to dementia over time. 
 Attention is the fifth major area of cognition tested by most cognitive evaluation exams. 
The MMSE, MOCA, COGselftest, TMT, and clock draw test all test some aspects of attention. 
Attention as a cognitive process is the ability to concentrate on a single aspect of the 
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environment or task (Cogselftest.com, 2020). Attention deficits are often most notable in mid to 
late stages of most dementias. However, attention issues can be more prevalent in some 
dementias compared to others. Between Vascular Dementia and Alzheimer’s patients at similar 
stages in their diseases, Vascular Dementia patients showed increased deficit in reaction times 
and were less accurate on tests measuring sustained attention compared to Alzheimer’s patients 
(Mcguinness et al, 2010). Reaction time is an ideal indicator for attention because good reaction 
time requires strong cognitive ability in areas such as information-processing speed and response 
accuracy. Sustained attention, in this study, was measured using a variation of a Trail Making 
Test called a Color Trail Test. The strongest correlation of these scores was noted during the 
MMSE, which could suggest that the MMSE is capable of distinguishing between the two 
dementias based on attention performance. Attention, more specifically vigilance, has been 
found to be largely controlled by the fronto-parital areas of the cortex, especially in the right 
hemisphere (Sarter et al, 2001). Vigilance is an important indicator of attention because it relates 
to the ability for an individual to watch out for innocuous signals over an extended period. 
Attention is arguably the most crucial aspect of cognition to examine because it is the largest 
determining factor in a physician’s recommendation for patients to be able to continue many 
regular life activities. Patients who perform poorly in attention areas of cognitive assessment 
exams, like the Trail Making Test, are likely deemed unfit to continue aspects of life such as 
driving and are typically recommended to either be under regular supervision or be put into a 
memory facility. 
 Orientation is the final major area of cognition tested by cognitive evaluation exams. 
Testing orientation in patients is usually focused in two domains, those being, spatial orientation 
and temporal orientation. Spatial orientation can be tested by asking the patient the country, 
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state, and city they are in. Temporal orientation, on the other hand, can be tested by asking 
patients the year, month, and day of the week. Orientation testing is present in the COGselftest, 
MMSE, and MOCA. One major issue regarding orientation testing is its internal validity. 
Whereas patients with dementia may express more orientation deficits, other healthy patients 
may also not perform well at orientation tasks due to matters of circumstance (Gazova et al, 
2013). If a patient has to travel a distance for testing, they may not know the exact city or county 
they are in. Equally, healthy individuals may have not checked the calendar for what day of the 
month it is. Nonetheless, these individuals are still attributed with lower orientation performance 
based on circumstance rather than neurologic irregularity. MRI scans show that orientation 
related to space, time, and self are related to brain areas such as the precuneus, inferior parietal, 
and medial frontal cortex (Figure 4). 
Figure 4: MRI scan of a healthy brain showing activity during space, person, and time 
orientation tasks in the precuneus, inferior parietal, and medial frontal cortex. (Peer et al, 2015) 
 
  
 
Orientation tests may be one way to distinguish Alzheimer’s Disease from Vascular 
Dementia. In Alzheimer’s Disease, both allocentric and egocentric orientation deficits can be 
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witnessed. This differs from Vascular Dementia in which typically only egocentric deficits are 
observed (Coughlan et al, 2018). 
Types of Cognitive Exams 
Clock Draw 
The clock drawing test (CDT) is a nonverbal cognitive exam used to asses cognitive 
function. One of the first administered clock draw tests used in understanding cognitive ability was 
in the 1940’s by Edinburg neurologists Oliver Zangwill and Andrew Patterson (Puglionesi, 2016). 
From these clock draw tests, Zangwill and Patterson were able to attribute failings in typical 
function in the clock draw test to unilateral lesions on the parietal lobe. Clock draw tests are now 
one of the most used tests in determining cognitive function amongst physicians. The test requires 
use of cognitive functions such as attention, calculation, comprehension, construction, recall, 
registration, repetition, and writing (Khan, 2016). As such, it is ideal for assessing the general 
cognitive ability of those suspected of suffering from dementia. 
The clock draw test is administered to patients by a tester. They are handed a sheet of paper 
and asked to draw a clock. They are instructed to draw a clock with a traditional face, with all the 
numbers placed inside the clock, and to position the hands at a certain time. However, the time 
asked to set the hands to is not straight forward, “set the time to 7:25”. Rather, the instruction is 
slightly ambiguous to determine the patient’s comprehension, “set the time to 10 past 11:00”. The 
contour of the clock’s shape, presence and position of the numbers, and presence and correctness 
of the hands of the clock are used to determine the normalcy of the drawing. 
The clock draw test in one of the best and most functional cognitive assessment exams. It 
has many positive aspects that lead it to be very reliable for use even in the most severe of 
cognitively impaired patients. Firstly, it is a fully non-verbal exam. Many severe cognitively 
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impaired people are either unable to speak or have such an extreme case of disorganized speech 
that they are fully incomprehensible. Such barriers do not allow for other exams, such as the 
MMSE, MOCA, CST, or Verbal Fluency exams to be administered. As such, medical practitioners 
can administer a CDT to almost any patient, totally independent of severity of cognitive 
impairment, and still assess a multitude of cognitive domains. This can be used to monitor many 
aspects of cognition because it takes many regions of the brain to draw a clock. Many cortical and 
subcortical regions on both hemispheres of the brain, especially those of the frontal, temporal, and 
parietal regions, are necessary in clock drawing tasks (Freedman et al, 1994). This leads into the 
next massive benefit of CDT’s; they are very versatile.  
As previously stated, clock draw tests can be used to measure a vast array of cognitive 
domains such as attention, calculation, comprehension, construction, recall, registration, 
repetition, and writing (Khan, 2016). On top of its versatility, it is also the easiest cognitive 
assessment exam to administer. Even the most severe of cognitively impaired patients can usually 
understand the premise of the exam and it takes little time to complete. Yet still, on top of its utility, 
it is an exam that can reliably be used to monitor for cognitive impairment.  
A meta-analysis of the reliability of CDT’s to identify cognitive impairment found that 
they can be used reliably, and with high accuracy, to differentiate between those who have, and do 
not have, cognitive impairment (Aprahamian et al, 2009). One study even found that the sensitivity 
and specificity rivaled that of even well performing MMSE studies where they were 87 and 86 
percent respectively (Tombaugh and McIntyre, 1992). Sensitivity, in relation to cognitive testing, 
is the ability for a test to correctly identify those with a cognitive disorder. Specificity, on the other 
hand, is the degree to which a test can correctly identify those without a cognitive disorder. The 
only noticeable downside to CDTs is that they cannot look into exact areas of cognition that are 
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impaired with as much accuracy as other exams like the MMSE and MOCA. That is because those 
exams have entire sections devoted to specific areas of cognition whereas they have to seemingly 
be deciphered from clock draw tests. Nonetheless, CDT’s are a tried and true reliable cognitive 
assessment exam with high ability in discriminating healthy and cognitively impaired individuals 
while assessing multiple areas of cognition in a vast array of patients. 
Verbal Fluency Exams 
 Verbal fluency exams are a type of cognitive testing that specialize in determining 
executive function (Shao, 2014). They are good indicators of executive function as it forces the 
patient to recall words from their vocabulary and make certain not to repeat them once stated. As 
such, Verbal Fluency Exams are the ideal exam in measuring verbal capability while also testing 
for executive function. These tests are easy to administer and reliable in the sense that even patients 
who have severe cognitive impairment can undergo this exam. These tests can either be semantic, 
where patients list animals, fruit, or vegetables, or phonetic, where the patient lists words starting 
with a certain letter. These tests usually allow the patient 60 seconds per section and each test 
typically has three sections. 
 Both the phonetic and semantic fluency exams are oral cognitive exams administered by a 
tester. For the phonetic exam, patients are given one minute in which they have to say all the words 
they can think of that start with certain letters. The words can be any the patient choses, so long as 
they are not the names of people, places, or numbers. Usually, the three letter the patients do this 
with are “F”, “A”, and “S”. An abnormal score for each is considered less than 12 unique words 
in the allotted minute. In total, a normal score for the entire phonetic section is 36 combined unique 
words. The semantic exam is similar to the phenetic exam. In this exam, the patient is presented 
with a category, and they must name all of the objects in that category they can think of within a 
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minute. The three usual categories used are animals, vegetables, and fruit. An abnormal score for 
each section is anything less than 13 unique objects for each section. In total, a normal score for 
the entire semantic section is 39 combined unique objects. 
 One of the largest benefits of verbal fluency tests are their high face validity. They are very 
direct in what they measure as someone who struggles with either executive cognitive impairment 
or verbal impairment will undoubtably perform poorly on this exam. It has been determined that, 
in the case of cognitive impairment, verbal fluency impairment begins to develop upon reaching 
amnestic MCI and worsens as a patient progresses into early and late stage dementia (Nutter-
Upham et al, 2008). As such, verbal fluency exams can be used in assessing cognitive decline over 
a patient’s diagnosis of cognitive impairment in areas related to executive function and verbal 
fluency. In fact, verbal fluency exams have been shown to accurately classify differing levels of 
cognitive impairment. Patients showed significant difference in performance on verbal fluency 
exams depending on whether they were healthy, had MCI, or had Alzheimer’s Disease (Bertola et 
al, 2014). Despite this, the efficacy of verbal fluency exams is disputed. Studies have shown that 
sensitivity of verbal fluency exams is around 76 percent while the specificity can be as low as low 
as 57 percent (Muangpaisan, 2007). As such, the tests can be effective but, due to them being 
relatively unreliable, should not be solely relied on in measuring overall cognitive impairment. 
Trail Making Tests 
 Trail making tests (TMTs) are some of the most widely used forms of cognitive 
assessment in clinical settings. Versions the TMT are even present in larger, more formal exams, 
such as the MOCA. The first trail making rest was used in 1944 by the Canadian Army in the 
hopes to provide insight into cognitive aspects such as visual search, scanning, speed of 
processing, mental flexibility, and executive functions (Tombaugh, 2004). The application of this 
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exam in use for cognitive impairment assessment was noted and later included in the Halstead–
Reitan Battery cognitive exam. The TMT is a four-part exam that focuses on connecting dots in a 
specific order. 
 The trails cognitive test is a written cognitive exam administered to a patient via a tester. 
This exam is composed of four parts, two sample portions and two tested portions. To start with, 
the patient completes the sample of the easiest of the two tested parts. The sample is composed 
of eight circles. Each circle has a number inside of it with a range of 1-8. The patient is asked to 
draw a continuous line starting from the number 1, between the circles in increasing order. This 
much resembles a connect the dots art piece given to children. The tester then notices whether 
the patient successfully completes the trial portion. Successful trials include the patient drawing a 
continuous line that connects the numbers in the correct order. If this is not done, the patient has 
failed the trial and is not administered the tested portion. If the trial is successful, the patient 
moves onto the tested portion.  
The tested portion is set up in the same manner as the trial, only this time there are 25 
circles for the patient to connect. For this portion, the tester records the amount of time it takes 
for the patient to connect all the dots. After, the number of errors made is assessed and recorded 
by the tester. These include the patient skipping a number or not drawing a continuous line. 
Afterwards, the patient is given the next trial trail.  
The patient is given this trial regardless of their performance on the previous two 
portions. On this trial, eight circles are present and have either the numbers 1-4 or the letters A-
D. The patient is then instructed to draw a continuous line from number to letter in increasing 
order, starting with the number 1. They are also prompted on how to start by the tester saying, 
“for example, draw from 1, to A, to 2 and so on and so forth”. Performance is assessed in the 
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same manner as the first trial to determine whether to patient passed or failed. Again, like the 
first trial, if the patient failed, they are not presented with the tested portion of the exam. If they 
do however pass, they are presented with a sheet with 25 circles including the numbers 1-13 and 
the letters A-L. Much like the trial, the patient is instructed to draw a continuous line from 
number to letter starting with the number 1. The tester records the time it takes for the patient to 
complete this and the amount of errors present. The errors include not drawing a continuous line 
and drawing the line in the incorrect order 
The largest issue regarding trail making tests is that there are few sets of norms to 
compare a patient’s results to. Unlike tests like the MMSE or MOCA that have a specific cut-off 
score for cognitive impairment, TMTs largely rely on measuring the time it takes for a patient to 
complete the trail and the number of errors the patient makes to determine impairment. The idea 
is that the more severe the cognitive impairment in related cognitive domains, the longer the test 
takes, and the more errors are committed. However, TMTs have been found to have very low 
sensitivity and specificity in comparisons between patients at varying levels of cognitive 
impairment.  
Figure 5: Percentage of individuals with no cognitive impairment (control), MCI, and Alzheimer’s 
Disease (AD) compared to number of errors made on Trail Making Tests(Ashendorf et al, 2008) 
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Whereas it can be noted that there is a decrease in healthy individuals making more mistakes, the 
number of mistakes for MCI and AD patients remains relatively proportionate to each other 
(figure 5). This study in which this came from, Ashendorf et al, measured number of errors and 
time to complete a TMT naming a control group, group of MCI patients, and group of 
Alzheimer’s patients. They found that time of completion was wore of a determining feature of 
cognitive impairment than age. Even then, there are still a substantial number of healthy 
individuals who make multiple mistakes on TMT’s. As such, this test cannot be reliably used to 
assess varying levels of cognitive impairment. 
COGselftest 
 The COGselftest was created in 2002 by Dr. John H. Dougherty (Cogselftest.com, 2020). 
It was developed with the intention to increase public awareness and early screening for 
cognitive impairment in the hopes of lowering the number of undiagnosed neurocognitive 
diseases among the public. The idea was that making neurocognitive testing more accessible to 
the public would increase the number of people checking their cognitive ability. This, in turn, 
would result in more people contacting physicians about possible cognitive issues and more 
extensive testing. The test is used to try and help identify cognitive impairments at the earliest 
stages possible. This is done in the hopes of maximizing the effectiveness of treatment due to the 
fact that treatment is more successful the earlier the disease is diagnosed. The test started as a 
written exam, and then was recreated into an online version in order to further increase 
availability and access. Unfortunately, no tests have seemed to be conducted measuring the 
concurrent validity between the written and online versions of the COGselftest. Such an 
experiment would be good to compare the accuracy of both types of test administration. 
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In clinical settings, the patient sits down with a tester who guides them through the test. 
The patient is asked to point at their answers on the computer screen while the tester inputs them 
into the computer to avoid further confusion. The test starts by gathering information about the 
patient including their age, sex, and highest level of education completed. The patient also is 
asked whether they have a family history of cognitive impairment and whether they themselves 
believe that they suffer from cognitive impairment. Then, patient is asked to complete a 
computer-generated Clock Draw Test in the same way as the previous CDT was described. After 
this, the patient is asked to read aloud three words that pop up on the computer screen. Once the 
patient has said the words aloud, they are asked to memorize the words and are informed they 
will be asked about them later. Directly after, the patient is instructed to list 15 different types of 
animals. The tester takes note of the animals listed while the patient lists them. After this, the 
patient is asked to recall the three words they were told to remember. After that, the patient is 
presented with a list of the months and is asked to, starting with the month December, list the 
next five months in reverse order. Finally, the patient is asked questions related to orientation. 
These include asking for the year, the day of the week, and the month. After this, the computer 
version of the COGselftest is automatically graded by the computer and a grade of excellent, 
needs work, or below average is given in each of the six major areas of cognition previously 
discussed. 
The COGselftest is one example of computerized cognitive exams that can be either self-
administered or administered in a clinical setting. The main focus of these computerized self-
tests is to be able to distinguish between healthy patients, patients suffering from MCI, and those 
who are suffering from advanced dementia like Alzheimer’s Disease. They are also used in the 
hopes of monitoring the potential changes in severity due to cognitive decline of dementia 
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patients as they progress through their illness. Many computerized self-tests, including the 
COGselftest, resemble large established tests such as the MMSE and MoCA exams. As such, 
they have similar layouts and test for the same big six areas of cognition.  
In a 2010 study by Dougherty et al, the validity of the CST tested alongside that of other 
cognitive exams such as the MMSE. With a sample size (n = 215) included people without 
cognitive impairment, with MCI, and with Alzheimer’s Disease, and the CST accurately 
classified 96 percent of patients based on their cognitive impairment (Dougherty, 2010). 
Accurate classification was dependent on the patient’s level of performance matching with their 
level of cognitive impairment. The more cognitively impaired the patient, the lower the score 
they would acquire. This compares to the 71 percent accuracy of the MMSE and the 69 percent 
accuracy of the Mini Cog. Along with this, the CST also correctly identified patients in six 
experimental groups, those being control, MCI, early Alzheimer’s, mild to moderate 
Alzheimer’s, moderate to severe Alzheimer’s, and severe Alzheimer’s, with 91 percent accuracy 
(Dougherty, 2010). This was vastly superior to that of the other exams where the MMSE only 
showed 54 percent accuracy and the Mini Cog only showed 48 percent accuracy. Sensitivity and 
specificity are important measures in testing because they show the accuracy of the test. High 
sensitivity and specificity would indicate a test with high internal validity (figure 6) 
Figure 6: Sensitivity vs Specificity of CST, MMSE, and Mini-Cog exams in detection of 
cognitive impairment plotted on a receiver operating characteristic curve. As shown, the CST 
almost exactly follows the left-hand and top border of the ROC space indicating that the test has 
very high accuracy. (Dougherty, 2010) 
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Severity of cognitive impairment on the CST is measured on a thirty-point scale. All of 
the questions on the CST result in a score out of thirty with each of the six major tested domains 
of cognition each being assigned a portion of this total score. This allows testers to observe the 
overall quality of cognition (figure 7) in a patient while also allowing them to see how specific 
areas of cognition may be impacted. 
Figure 7: CST total score in relation to severity of cognitive impairment from sample n = 215. 
Asterisks indicate significant difference from control. Ranges of scores for each severity level 
derive from CST performance from individuals with that respected level of cognitive 
impairment. (Dougherty, 2010) 
 
Meghreblian 
 
23 
 
 
As can be noted, and would be expected, CST total score steadily decreases along with severity 
of cognitive impairment. As such, the COGselftest can reliably be used to measure the decline in 
cognitive ability between large groups of patients. However, it may be more difficult to monitor 
the steady decline of an individual’s level of cognitive impairment. As can be seen in figure 7, 
there is considerable overlap between levels of impairment severity. For instance, a score of 24 
seems to be within the range of healthy controls, those with MCI, and those with early AD. That 
could mean a patient could have progressed from healthy to early Alzheimer’s and maintained a 
consistent score.  
 When distinguishing between a large group of healthy patients, those with MCI, and 
those with Alzheimer’s, the COGselftest has proven to be an accurate and reliable tool for 
distinguishing between these states. Furthermore, it has been shown to be reliable in accurately 
showing the severity of cognitive impairment amongst afflicted individuals. However, the 
COGselftest still can be improved upon. A primary concern about this exam is the apparent lack 
of clarity in its ability to distinguish between MCI and Alzheimer’s with other types of dementia 
like Vascular Dementia. Although general severity of cognitive impairment is still accurately 
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measured, the COGselftest is unproven in its ability to distinguish between types of dementias. 
As such, it can only reliably be used to measure cognitive impairment and not be used for 
distinguishing between dementias. Another issue regarding the COGselftest is it’s the seeming 
lack of deviation in scores between healthy patients, those with MCI, and those with early AD. 
As shown in figure 7, people with these levels of severity can obtain the same score. This would 
prove the COGselftest ineffective in differentiating between these states. This is especially 
problematic when realizing the main function of this exam is to identify early cognitive 
impairment in individuals in order to implement early intervention. 
MMSE 
The MMSE, Mini-Mental State Examination, was created in 1975 by M. F. Folstein et al. 
with the intention of helping to evaluate cognitive impairment in older adults (IHPA, 2020). It is 
a test based on a 30-point scale that can be used to asses a person’s ability to think, 
communicate, understand, and remember. Although the exam can be used to test the mental state 
of patients who have recently suffered a head injury or infection, it is largely used in assessment 
of patients suspected of having some form of dementia. The MMSE can be used to assessed 
cognitive abilities such as short term and long-term memory, attention, concentration, language 
skills, communication skills, and ability to understand instructions (Healthdirect, 2019). This test 
is good in determining the overall cognitive impairment of a patient with dementia but is not 
meant to distinguish between types of dementia. The MMSE is used over a period of time to 
assess the gradual increase or decrease in cognitive ability of a patient. 
The MMSE is split into five separate sections, those being, Orientation, Registration, 
Attention and Calculation, Recall, and Language. These five sections are used to assess the six 
major areas of cognition previously discussed. The patient is asked by the tester to list the current 
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year, season, date, day of the week, and month to test their temporal orientation. The temporal 
orientation section is worth a total of 5 points. Next, the patient is asked to name the country, 
state, county, city, and clinic they are currently in to test their spatial orientation. The spatial 
orientation section is also worth a total of 5 points. This totals the worth of the orientation section 
to 10 total points. Next, the patient is asked to repeat three words the experimenter presents to 
them aloud. For example, the experimenter would say the words, “apple, book, coat” giving one 
second between each word so that they are clearly presented and then the patient is expected to 
say these three words back to the tester. This section worth three total points. The tester then asks 
the patient to remember those three words as they will need to recall them later. The tester then 
moves on to the Attention and Calculation section.  
This section can be conducted in two different ways. The tester can either present the 
patient with a serial subtraction test where the patient subtracts 7 from 100 and then from all 
their corresponding answers until they get to 65. Alternatively, the tester can have the patient 
spell the word “world”. If the patient has a hard time spelling the word, the tester will walk them 
through each letter. Then, the tester will ask the patient to spell the word “world” backwards. 
Whichever way this section is conducted, it is worth 5 points. Next, the patient is tested on their 
recall ability. The patient is asked to recall the three words presented to them from the 
registration section. Each correct recall is worth 1 point, totaling the section value to 3 points. 
Finally, the patient is tested on the largest section of the MMSE, language.  
The patient is first shown a pen and then a watch and is asked to identify both the objects. 
Correct identification of each object is worth 1 point per object. Next, the patient is asked to 
repeat the following sentence, “No ifs, ands, or buts”. The patient must say the sentence exactly 
that way in order to receive the point this part is worth. Next, the patient is tested on their ability 
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to follow a multi-step command. They are told that they must take a piece of paper in their right 
hand, fold it in half, and then place the paper back on the tester’s clipboard. This section is worth 
three points. The patient’s reading ability is then tested. They are told that they will be presented 
with a sentence and that they must first say it aloud and then do what the sentence says. The 
patient is then shown a sentence like “close your eyes”. Finally, the patient is tested on their 
ability to copy. The patient is presented with a figure consisting of two overlapping pentagons 
and told to copy the figure in a space provided. The figure must be closed at all points and have 
the four-sided diamond where the figure overlaps. If either of these two qualifications are not 
met, the patient does not receive the point. The final total is then calculated, and the patient’s 
score is determined out of 30 points. 
The severity of cognitive impairment can be determined by the score obtained from this 
exam. However, the cutoff for normal vs abnormal scores depends on the level of education the 
patient has received. A patient with an education level of 7th grade or lower has a normal score as 
low as 22/30. Those who have an 8th grade or some high school education have a normal score of 
24/30. Those with a complete high school education can have a normal score as 25/30. Those 
who have a college level or higher education can have a normal score of 26/30. However, the 
typical baseline for severity is set at a score of anything below 25 being abnormal. Mild 
cognitive impairment would then be indicated by a score of 21-24. Moderate cognitive 
impairment is determined within the score range of 10 and 20. Severe cognitive impairment is 
represented by a score lower than 10 (Mini-mental state exam, 2005).  
Much like the COGselftest, the MMSE can only be reliably used in measuring the 
severity of cognitive impairment while not being able to necessarily distinguish between types of 
dementia. Unlike the COGselftest however, the MMSE has the benefit of factoring level of 
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education into its scoring. This is an important aspect to consider in analyzing cognitive testing 
due to the extent in which level of education can impact performance on cognitive assessment 
exams regardless of cognitive impairment. In fact, level of education has been shown to have 
more of an influence over cognitive assessment scores than even age (Azeredo et al, 2015). 
Aside from this benefit however, the MMSE has some large pitfalls. The MMSE has a fairly low 
sensitivity range in detecting cognitive impairment, only 45-60 percent. The specificity of 
detection for cognitive impairment is better, between 65-90 percent, but still has too large of as 
range with a low bottom end to be considered highly accurate (Langa and Levine, 2014). This is 
especially true when compared to cognitive evaluations such as the COGselftest. Such low 
specificity and sensitivity to detection greatly cripples the reliability of this exam as it does not 
allow for great distinction in severity of cognitive impairment. Such low sensitivity likely leads 
to floor and ceiling effects, limiting its real effectiveness in clinical settings to diagnose 
dementia. 
MOCA 
 The MOCA, or Montreal Cognitive Assessment, was created by Dr. Ziad Nasreddine in 
1995 (Hobson, 2015). The purpose of the MOCA is to aid in the diagnosis for mild cognitive 
impairment or early stage dementia. This exam, much like the MMSE and COGselftest, is set on 
a 30-point scale. Score ranging between 26-30 is considered a normal score (Hobson, 2015). The 
main cognitive domains that the MOCA tests are Visuospatial/Executive, Naming, Memory, 
Attention, Language, Abstraction, Delayed Recall, and Orientation to both time and location. 
The exam combines many typical cognitive screenings such as a clock-draw, trail-making, 
sustained attention task, and serial subtraction. As such, the MOCA is arguably the most 
versatile cognitive exam available in regard to the relatively short time it takes to administer. 
Meghreblian 
 
28 
The patient is administered the MOCA via a tester. First, the patient is tested on their 
visuospatial/executive function. This is done through a trail test, drawing challenge, and clock 
draw. The trail making portion is identical to the TMT previously presented. Next, the patient is 
presented with a cube, and asked to draw the cube as they see it. Finally, the patient is asked to 
draw a clock. The clock drawing portion is identical to the instructions previously described for 
the Clock Drawing Test. This section is worth a total of 5 points. 
Next, the patient does a naming task. They are presented with three animals (a lion, 
rhinoceros, and camel) and asked to identify them. This naming task is worth 3 total points. The 
patient is then tested on their memory. They are presented with a list of five words and asked to 
repeat the list after the tester finishes presenting the list. For example, the words can be face, 
velvet, church, daisy, and red. The tester presents the patient with this list twice, with the patient 
repeating the list after each time. The specific words the patient recalls are recorded, and then 
they are asked to memorize the words because they will be asked about them later. 
After, the patient is tested on their attention. First, the patient is given a list of five 
numbers and asked to repeat the list back to the tester. The patient then is given a list of three 
numbers and asked to say them in reverse order from how they were presented. This section is 
worth 2 points. The patient then is given a pen and asked to tap their chair once. They are told 
that each time the letter A is said in the following list of letters, they are to tap their chair one 
time. A long list of letters is then read aloud with the instructor saying one letter every second. 
For this section, the patient is allowed to make two errors and still get the point. This section is 
worth one point. Finally, for this section, the patient does a serial subtraction test. This section is 
identical to the serial subtraction test described previously in the MMSE. This section is worth 3 
points. 
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After attention, language is then assessed. Firstly, the patient is presented with a sentence 
the tester says aloud and asked to repeat it. The same process is repeated afterward with a 
different, more complex, sentence. Each sentence is worth one point which is awarded if the 
patient says to sentence exactly as it is presented. Next, the patient does a phonetic test. They are 
given one minute and are told to say all the words they can think of that start with the letter F. 
The patient must say at least 11 unique words that fit the criteria of the instructions within the 
minute in order to receive the one-point credit. 
Abstraction is tested next. For this section, the patient is asked to tell the similarities 
between two different sets of two words. For example, they are asked to give a similarity 
between a train and a bicycle, and between a watch and a ruler. However, the patient only 
receives credit if they say that the similarities between a train and a bicycle is that they are forms 
of transportation and that a watch and a ruler are both tools used for measurement. Other 
similarities such as “both have wheels” or “both have numbers” are not given credit. This section 
is worth 2 points. 
The patient is then tested on their delayed recall. They are asked to recall the five words 
they were presented with during the memory section of the exam. This section, unlike the others, 
has a secondary score attribute called the MIS. If the patient gets a word right without hints, they 
are given three points towards their MIS score. If they get it with one hint, they receive two 
points to their MIS score. If they get it with two hints, they receive one point to their MIS score. 
If they don’t recall the word after two hints, they do not receive any points to their MIS score. 
The MIS section totals 15 points. These points do not affect the overall 30-point scale but are 
their own section and used to assess how poor the patient performed in their delayed recall. 
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Finally, the patient is tested on their orientation to both time and location. The tester asks 
the patient four questions related to time, asking for the date, month, year, and day of the week. 
Then, they ask two questions related to location, asking for the name of the clinic they are in (the 
doctors name can be used as a substitute if they don’t know the name of the clinic), and the name 
of the city they are currently in. The total value of the section to six points. Due to the intensity 
of the exam, one point is awarded to patients who have a level of education lower than a high 
school degree or equivalent. 
The MOCA is by all accounts the best cognitive test able to be used in determining 
cognitive impairment. It vastly outperforms older, more clinically established cognitive exams 
such as the MMSE. In 2005, Nasreddine et al sought to compare the MOCA and MMSE’s ability 
to measure cognitive impairment in patients. In a study with over 180 subjects, the MOCA vastly 
outperformed the MMSE in terms of sensitivity and specificity (figures 8 and 9). The MMSE 
only had a sensitivity level of detection for mild cognitive impairment of 18 percent. The 
MOCA, on the other hand, had a sensitivity detection level of 90 percent. For patients with 
Alzheimer’s, the MMSE had a sensitivity detection level of only 78 percent while the MOCA 
had a 100 percent detection sensitivity level (Nasreddine et al, 2005). The MOCA overall 
produced much more refined scores which would help it better distinguish level of severity of 
cognitive impairment compared to that of the MOCA due to not showing a floor or ceiling effect. 
Figure 8: Average MMSE and MOCA scores for normal controls (NC), MCI patients (MCI), 
and Alzheimer’s patients (AD) (Nasreddine et al, 2005) 
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Figure 9: Scatter plot for MOCA and MMSE scores for normal controls (NC), MCI patients 
(MCI), and Alzheimer’s patients (AD). The MOCA shows better deviation in scores based on 
severity levels compared to the MMSE. This can contribute to the MOCA having higher 
accuracy in determination of impairment severity. (Nasreddine et al, 2005) 
 
 
 
One of the most important findings in this study was the MOCAs superior ability to 
distinguish healthy patients and patients with MCI. In this test, the majority of NC patients 
scored in the normal ranges for both the MMSE and MOCA while the majority of AD patients 
scored in the abnormal range for both of these tests. However, three-fourths of the MCI patients 
who scored abnormal on the MOCA scored normal on the MMSE (Nasreddine et al, 2005). As 
such, this should establish the MOCA as the primary cognitive assessment exam used to 
distinguish healthy patients to those with MCI. The MOCA, much like the MMSE, also has the 
added benefit of accounting for level of education when determining final score and level of 
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cognitive impairment. Unlike the MMSE however, the MOCA provides a more modest 
correction for education level which could create a situation where patients with lower levels of 
education are being unfairly shown as more cognitively impaired than they actually are. 
 
Conclusion 
One of the largest issues with cognitive assessment exams is their standardization. The 
sensitivity and specificity of every cognitive exams seems to change dramatically between 
different studies. The low replicability of these exams is troubling as it calls into question the 
general reliability of these exams to properly assess severity of cognitive impairment. This is 
especially problematic when considering that massive life altering decisions, such as limiting 
ability to drive and moving patients into memory care institutions, are based on the results of these 
exams. The massive swings in sensitivity and specificity between each test greatly calls into 
question the ability of these tests to perform their intended purpose. This potentially could stem 
from a lack of standardization among these cognitive assessment exams. This could potentially be 
fixed by making tester instructions much clearer. Whereas it is unreasonable to assume each tester 
will conduct an exam in the exact same manner as the next, clarifying tester instructions in how to 
ask questions may lower this issue. Another reason this variation may be present is that grading 
each response is very situational and largely must be decided by the tester. Bias that the tester may 
have towards a specific patient may influence their grading of performance. This is where 
computerized tests benefit over written tests because the computer program will grade 
indiscriminately. This issue could be fixed on written exams by having a more extensive grading 
rubric available to the tester. 
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 Another way that diagnosis and monitoring severity of cognitive impairment could 
improve is by administering many cognitive assessment exams in the same sitting. Whereas each 
exam has unique approaches to monitoring cognition, each essentially assess the same six major 
areas of cognition. Those being visual spatial, executive functions, verbal fluency, memory, 
attention, and orientation. Administering many cognitive exams at once would have the benefit of 
monitoring each of these domains two or three times over. This would allow for multiple readings 
that could be compared to one another to accurately assess cognitive impairment with more 
certainty.  
Cognitive assessment exams are an essential tool clinicians use to monitor and determine 
severity of cognitive impairment in patients with MCI and dementia. They are instrumental in 
understanding what areas of cognition are impacted and to the extent they affect a patient’s 
behavior. Cognitive assessment exams allow medical practitioners to examine how 
neurophysiologic degeneration, observed through neuroimaging, impacts dementia patient’s 
ability to conduct routine tasks that impair their daily lives. These exams are critical in the 
assessment of cognitive impairment severity in dementia patients and without them our 
understanding and ability to treat these patients would be significantly hampered. 
However, cognitive assessment exams in general can still be improved. Modern cognitive 
exams fail in their ability to distinguish between types of dementia. At present, they can only 
monitor level of severity for those who are cognitively impaired. Future improvement to these 
exams can be aimed at distinguishing between types of dementia. Future studies could focus on 
localizing impairment of major cognitive functions to specific dementias. That way, when a patient 
is administered a cognitive exam, medical practitioners can observe the major deficits and narrow 
down their diagnosis. Of course, this would only further improve the accuracy of diagnosis and 
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thus improve the care plan for the patient. It is important to realize, however, that cognitive 
assessment exams will always be one of many factors contributing to the diagnosis of a patient. 
These exams will be one tool in the toolbox used by healthcare providers alongside neuroimaging, 
genetic factors, and environmental factors of the patient. Even then, making these improvements 
to increase the accuracy of these exams will only further supplement quality patient care. 
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